MedPath

Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents

Not Applicable
Completed
Conditions
Sexually Transmitted Diseases
Substance-Related Disorders
Interventions
Behavioral: Partner-Specific IMB-based HIV risk reduction intervention
Behavioral: Healthy Lifestyle
Registration Number
NCT00831883
Lead Sponsor
Women and Infants Hospital of Rhode Island
Brief Summary

The purpose of this study is to develop and pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use.

Detailed Description

Incarcerated adolescents represent a group at high risk for health consequences associated with risky sexual behaviors. Condom use is more common with non-main than main sex partners and substance use in conjunction with sexual risk also appears to vary by partner type. The research team will conduct a small randomized trial to pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use. Participants will be randomized to a 5 session HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model, or a 5 session healthy lifestyles psychoeducation intervention, and then reassessed 3 months after their access to the general community is reinstated. The main hypothesis is that participants in the HIV risk reduction intervention condition will have lower levels of sex-related HIV risk behavior and of substance use in conjunction with sexual risk, relative to those in a healthy lifestyles psychoeducation intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • English-speaking ability
  • unprotected vaginal, anal, or oral intercourse at least once in the 6 months prior to incarceration or placement
  • marijuana use disorders, other non-injection drug use disorders, or substance use by a sexual partner during a sexual episode in the six months prior to incarceration or placement
  • sentence or placement length between 2 and 12 months
  • must plan to remain in the area for the 6 months following their release from the facility
  • must be willing to provide two pieces of contact information for follow-up
Exclusion Criteria
  • signs of psychosis (assessed through clinical assessment)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Partner Specific IMBPartner-Specific IMB-based HIV risk reduction interventionpartner-specific HIV risk reduction intervention
HLSHealthy Lifestyle5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.
Primary Outcome Measures
NameTimeMethod
lower levels of sex-related HIV risk behavior3 months
Secondary Outcome Measures
NameTimeMethod
knowledge about STI transmission3 months
partner-specific perceptions of STI risks3 months
social norms, expectations and personal attitudes regarding partner-specific sexual behavior3 months
partner-specific behavioral and communication skills3 months

Trial Locations

Locations (1)

Women & Infants Hospital of Rhode Island

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath